Skip to content
FHI 360
  • Languages
  • Low bandwidth
  • High bandwidth
  • Search
  • Who we are
        • Who we are
          • About us
          • Leadership
          • Ethics and safeguarding
          • Impact and financial reports
          • Contact us
        • About us

          Impact and financial reports

  • What we do
        • What we do
          • Economic opportunity
          • Health


        • How we do it
          • Research in action
          • Humanitarian response
          • Digital innovation and AI
        • Explore our expertise
        • Economic opportunity

          Health

  • Where we work
        • Where we work
          • Asia Pacific
          • Central Africa
          • East Africa
          • West Africa
          • Southern Africa
          • Middle East and North Africa
          • Europe and Central Asia
          • Latin America and the Caribbean
          • United States
        • Around the world

          In the United States

  • Work with us
        • Work with us
          • Join our team
          • Local partners
          • Government and multilateral funders
          • Foundations and corporations
          • Academic and research partners
          • Small businesses and vendors
          • CEO position specification
        • Join our team

          Local partners

          Government and multilateral funders

          Foundations and corporations

          Academic and research partners

          Small businesses and vendors

  • News
        • News
          • Newsroom
        • Get the latest news
        • Newsroom

  • Stories
        • Stories & blog
          • Stories
          • Videos (YouTube)
          • Blog
        • Explore our storytelling
        • Our storytelling

          Blog

  • Resources
        • Resources
          • Resource library
        • Resource library

Home | Articles | Partnering with the private sector to vaccinate for COVID-19 along work commutes
April 20, 2023

Partnering with the private sector to vaccinate for COVID-19 along work commutes

Imagine this: It’s a weekday morning. You head to the train station to get to work. But before you board the train, you come across a team of health care workers offering COVID-19 vaccinations right there in the station. COVID-19 cases are rising, and getting vaccinated here at the station means you won’t need to visit a health facility to gain protection against illness and death. So, after getting the shot, you board the train and get on with your day.

For nearly 2,000 people in Jakarta, Indonesia, this scenario really happened. It was part of a concerted effort to mitigate the surge of COVID-19 caused by the delta variant in August 2021. The Meeting Targets and Maintaining Epidemic Control (EpiC) project, led by FHI 360 and funded by the U.S. Agency for International Development (USAID), partnered with provincial governments in Indonesia to recruit more health care workers and hold mass vaccination events.

people in station waiting on line

The COVID-19 vaccination event at the train station was part of an effort to combat the highly contagious delta variant of the coronavirus, which was wreaking havoc in Jakarta. Facilities were full and understaffed, and health care workers were overwhelmed. Also facing severe health worker shortages were West Java and Banten provinces, which were some of the regions of the country most burdened with COVID-19. The surge of cases and the staff shortage presented a new challenge for the country in achieving its goal of vaccinating 70% of the eligible population.

The provincial health authorities in these areas asked the Ministry of Health and USAID for help. The EpiC project was identified to support the Indonesian government’s COVID-19 vaccination efforts, as EpiC had been providing technical assistance for the Ministry of Health in addressing the HIV epidemic.

In collaboration with the Ministry of Health, EpiC mobilized more than 3,000 private sector doctors, nurses and midwives, who administered more than 1.7 million doses of COVID-19 vaccines during a nine-month period between fall 2021 and spring 2022.

Three private companies who wanted to support Indonesia’s vaccination efforts and the safe reopening of the country’s economy also joined the effort. They came from different industries but shared the goal of helping the country combat COVID-19: Commuter Train Indonesia, which runs the trains that thousands of people take to work; Grab, a leading ride-hailing platform; and Traveloka, an online travel company. EpiC and the Indonesian government collaborated with these companies to accelerate COVID-19 vaccination coverage.

Public vaccination events at train stations were led by Commuter Train Indonesia; its subsidiary, PT Kereta Commuter Indonesia, owns commuter train stations in and around Jakarta. EpiC partnered with PT Kereta Commuter Indonesia and the Jakarta Provincial Health Office to hold nine mass vaccination events at train stations in the greater Jakarta region. Local health authorities selected the train stations because of their high daily passenger loads and low vaccination rates in the surrounding areas.

“Most citizens of greater Jakarta use the train to commute to work each day, so trains are packed during rush hour,” says Saskia Mariska, senior technical officer for EpiC Indonesia at FHI 360.

These nine vaccination events resulted in the administration of more than 1,700 vaccine doses. They also raised the public’s awareness of the urgency to get vaccinated against COVID-19, because at that time most people had only received their first dose.

“Most commuters are workers who leave early in the morning and get back late at night,” says Mariska. “It would have been difficult for them to find time to get vaccinated for COVID-19 if they had to go to a health facility. These train station vaccination events were very convenient for them.”

smiling people in group


All photos above, which show vaccination sites in and around Jakarta, Indonesia, are credited to EpiC Indonesia. ​​​​The EpiC project is funded by USAID through PEPFAR (the U.S. President’s Emergency Plan for AIDS Relief). It is dedicated to achieving and maintaining HIV epidemic control and leverages its infrastructure and partnerships to address other priority public health challenges, including COVID-19 and mpox.

EpiC Indonesia has also partnered with the private sector to increase COVID-19 vaccination coverage among the country’s older population. Read about those efforts on the EpiC blog.

Share article
Back to top

Related articles

News
FHI 360’s rapid response to the Ebola virus in the DRC
June 12, 2026
News
New AI chatbot aims to boost teacher pedagogical support
May 11, 2026
News
Why more employers are turning to apprenticeships — and seeing results
April 24, 2026

On this page

FHI 360

We are a nonprofit organization that mobilizes research, resources and relationships so that people everywhere can access the opportunities they need to lead full, healthy lives.

  • Partner with us
  • Business opportunities
  • Contract mechanisms
  • Small business
  • Our FHI 360 network
  • Events
  • Employee access
  • Contact us
  • Press
  • Privacy notice
  • Ethics and safeguarding

FHI 360 Headquarters
359 Blackwell Street, Suite 200
Durham, NC 27701 USA
1.919.544.7040

Washington, D.C., Office
2101 L St NW, Suite 700
Washington, DC 20037 USA
1.202.884.8000

Anti-trafficking statement

Connect

Sign up for our mailing list and receive the latest updates from FHI 360 straight to your inbox!

  • LinkedIn
  • Facebook
  • X
  • Youtube
  • Instagram

FHI 360 is the registered trade name of Family Health International.

©2026 FHI 360

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in .

FHI 360
Powered by  GDPR Cookie Compliance
Privacy overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Essential cookies

Essential cookies should be enabled at all times so that we can save your preferences for cookie settings. However, they can be enabled or disabled using the button below.

Non-essential cookies

This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.

Keeping this cookie enabled helps us to improve our website.